BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• FDA

  Samsung BioLogics Receives an additional FDA Approval for its world largest Plant’s Production

  3rd approval for Plant 2 in just 26 months since GMP ready

  May 24, 2018

   · 

  2 min read
• Business

  Softbox acquires Cold Tech Systems to further expand presence in Latin America

  Softbox announces the acquisition of Cold Tech Systems.

  May 24, 2018

   · 

  3 min read
• BioForest

  Kaiser Permanente Researchers Develop New Models for Predicting Suicide Risk

  Approach may offer value to health systems and clinicians in targeting interventions to prevent suicide

  May 24, 2018

   · 

  5 min read
• Business

  Vizient, Inc. Reports 26 New, Renewed or Expanded Agreements with Health Care Organizations in Q4 of 2017

  Vizient, Inc., continued to demonstrate growth and high member retention by announcing that it had closed 26 new, renewed or expanded agreements with health care organizations in the last quarter of 2017.

  May 24, 2018

   · 

  2 min read
• Drug Development

  Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development

  Curis, Inc. today announced that Robert Martell, M.D., Ph.D., has been appointed Head of Research and Development.

  May 24, 2018

   · 

  4 min read
• Drug Development

  BioTime Further Expands OpRegen® Clinical Trial in Dry-AMD With the Opening of Two Additional U.S. Sites

  Announced the expansion of its ongoing Phase I/IIa clinical trial for OpRegen®, with the addition of two new U.S. sites that are expected to begin treating patients later this quarter.

  May 24, 2018

   · 

  5 min read
• Drug Development

  Targovax Strengthens 2-year Survival Rate in Resected Pancreatic Cancer With TG01

  Median overall survival was 33.4 months compared to 27.6 months in the ESPAC4 trial

  May 24, 2018

   · 

  6 min read
• Biotech Beach

  Stellar Achieves Robust Viral Clearance for Manufacturing Process

  This clearance step is a key quality assurance milestone under Stellar’s initiatives to increase the scalability and throughput capacity of its manufacturing processes.

  May 24, 2018

   · 

  4 min read
• Pharm Country

  Celgene Corporation Announces Additional $3 Billion Share Repurchase Authorization and Plans to Execute a $2 Billion Accelerated Share Repurchase Program

  The planned ASR will utilize part of the existing Board authorized share repurchase program as well as part of the new authorization.

  May 24, 2018

   · 

  2 min read
• Business

  McKesson Reports Fiscal 2018 Fourth-Quarter and Full-Year Results

  Revenues of $51.6 billion for the fourth quarter and $208.4 billion for the full year.

  May 24, 2018

   · 

  56 min read